Lymphoblastoid cell lines models of drug response: successes and lessons from this pharmacogenomic model. [electronic resource]
- Current molecular medicine 2014
- 833-40 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1875-5666
10.2174/1566524014666140811113946 doi
Cell Line, Transformed Cost-Benefit Analysis Genome-Wide Association Study--economics Humans Lymphocytes--drug effects Models, Biological Models, Genetic Pharmacogenetics--economics Polymorphism, Single Nucleotide RNA Interference Reproducibility of Results Translational Research, Biomedical--economics